tiprankstipranks
Advertisement
Advertisement

GILD Stock Latest News

Gilead’s Arcus-Backed Cancer Trial Reaches Completion, Setting Up a Key Immuno-Oncology Catalyst
Company AnnouncementsGilead’s Arcus-Backed Cancer Trial Reaches Completion, Setting Up a Key Immuno-Oncology Catalyst
1d ago
GILD
Gilead Sciences Stock (GILD) Slips 2% Despite FDA Approval of Bixlenvo
PremiumMarket News
Gilead Sciences Stock (GILD) Slips 2% Despite FDA Approval of Bixlenvo
7d ago
GILD
Gilead’s Bixlenvo approved by FDA for virologically suppressed adults with HIV
PremiumThe Fly
Gilead’s Bixlenvo approved by FDA for virologically suppressed adults with HIV
8d ago
GILD
Lakefront Biotherapeutics granted orphan drug designation for gamgertamig
PremiumThe Fly
Lakefront Biotherapeutics granted orphan drug designation for gamgertamig
11d ago
GILD
LKFT
Gilead says EC grants marketing authorization for Trodelvy/Keytruda combination
PremiumThe Fly
Gilead says EC grants marketing authorization for Trodelvy/Keytruda combination
11d ago
MRK
GILD
Tempus AI Stock (TEM) Is Surging 24% on Wednesday – Here’s Why
PremiumMarket NewsTempus AI Stock (TEM) Is Surging 24% on Wednesday – Here’s Why
16d ago
MRK
TEM
MacroGenics receives $10M milestone after Gilead exercises license option
Premium
The Fly
MacroGenics receives $10M milestone after Gilead exercises license option
18d ago
GILD
MGNX
Gilead Sciences Earnings Call Highlights Strong Core Growth
Premium
Company Announcements
Gilead Sciences Earnings Call Highlights Strong Core Growth
19d ago
GILD
Gilead: Strong HIV and Oncology Growth Underpins Reiterated Buy Rating and Unchanged $165 Price Target
PremiumRatings
Gilead: Strong HIV and Oncology Growth Underpins Reiterated Buy Rating and Unchanged $165 Price Target
28d ago
GILD
Gilead files automatic mixed securities shelf
PremiumThe Fly
Gilead files automatic mixed securities shelf
29d ago
GILD
Gilead price target lowered to $150 from $156 at Truist
PremiumThe Fly
Gilead price target lowered to $150 from $156 at Truist
1M ago
GILD
Gilead: Buy Rating Reaffirmed on Strong Fundamentals and HIV Franchise Momentum; $165 Price Target Maintained
PremiumRatings
Gilead: Buy Rating Reaffirmed on Strong Fundamentals and HIV Franchise Momentum; $165 Price Target Maintained
1M ago
GILD
Gilead price target raised to $123 from $120 at RBC Capital
PremiumThe FlyGilead price target raised to $123 from $120 at RBC Capital
1M ago
GILD
Gilead Buy Rating Reaffirmed on Strong HIV-Driven Growth and Raised Revenue Outlook; $170 Price Target Maintained
Premium
Ratings
Gilead Buy Rating Reaffirmed on Strong HIV-Driven Growth and Raised Revenue Outlook; $170 Price Target Maintained
1M ago
GILD
Gilead Sciences: Strong Core Performance and Upgraded HIV Outlook Underpin Buy Rating and Earnings Power
Premium
Ratings
Gilead Sciences: Strong Core Performance and Upgraded HIV Outlook Underpin Buy Rating and Earnings Power
1M ago
GILD
Gilead reports Q2 adjusted EPS ($6.75), consensus ($7.25)
PremiumThe Fly
Gilead reports Q2 adjusted EPS ($6.75), consensus ($7.25)
1M ago
GILD
Gilead raises FY26 EPS view to (65c)-(30c) from ($1.05)-(65c), consensus (75c)
PremiumThe Fly
Gilead raises FY26 EPS view to (65c)-(30c) from ($1.05)-(65c), consensus (75c)
1M ago
GILD
Options Volatility and Implied Earnings Moves Today, August 04, 2026
PremiumMarket News
Options Volatility and Implied Earnings Moves Today, August 04, 2026
1M ago
ET
AMD
Gilead update on California ruling removes an overhang, says UBS
PremiumThe Fly
Gilead update on California ruling removes an overhang, says UBS
1M ago
GILD
Gilead’s GS-2426 Phase 1 Trial Targets MTAP-Deleted Tumors: What Investors Should Know
PremiumCompany AnnouncementsGilead’s GS-2426 Phase 1 Trial Targets MTAP-Deleted Tumors: What Investors Should Know
1M ago
GILD
Options Volatility and Implied Earnings Moves This Week, August 03 – August 06, 2026
Premium
Market News
Options Volatility and Implied Earnings Moves This Week, August 03 – August 06, 2026
1M ago
O
ET
Is GILD a Buy, Before Earnings?
Premium
Pre-Earnings
Is GILD a Buy, Before Earnings?
1M ago
GILD

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >